Viewing Study NCT00048633


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-31 @ 6:26 AM
Study NCT ID: NCT00048633
Status: COMPLETED
Last Update Posted: 2012-05-23
First Post: 2002-11-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer
Sponsor: QLT Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module